Convergence of CRISPR and Stem Cells is Changing Regenerative Medicine
Join Dr. Faizzan Ahmad, CEO of Cure8bio, as he explores the frontier of regenerative medicine. From his journey at Oxford to pioneering a hub-and-spoke biotech model, Dr. Ahmad discusses the latest advancements in stem cell therapies, gene editing, and their potential to cure previously untreatable diseases. Learn how these innovations are reshaping the future of healthcare and longevity.
More Episodes
Discover how Yaky Yanay, CEO of Pluri, is revolutionizing regenerative medicine using placenta-derived cells. From combating radiation...
Join Jess Larsen and co-host Greg Bailey as they welcome biohacking legend Bryan Johnson to explore the frontiers of health and longevity.
Lucio Iannone, VP of Venture Investments at Leaps by Bayer, shares insights on the future of biotech investment, focusing on cell therapy...
Gain crucial insights into the world of longevity investing with José Navarro-Betancourt—learn the keys to identifying promising biotech...
Discover how Aaron Alexander helped NFL star Aaron Rodgers achieve the fastest Achilles tendon rupture recovery ever using techniques...
The field of aging research is undergoing a revolution, and the Buck Institute is at the forefront of this transformative movement. In...
In this insightful podcast episode, Dr. Jeff Karp shares powerful strategies to tap into your brain's neuroplasticity and rewire it for...
Discover how Bayer's Leaps Venture Capital arm is transforming the biotech landscape by investing in cutting-edge therapies and...
What can we learn from an investor who has deployed over $100 million into longevity-focused biotech startups? Alex Colville...
Discover the immense potential of the longevity biotech field with insights from biotech investor Karl Pfleger.
The Buck Institute, a pioneer in aging research, is uncovering how ketones impact healthspan. Dr. Brianna Stubbs, a world-champion...
